UBS Group’s Medidata Solutions, Inc. MDSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-77,531
| Closed | -$7.09M | – | 8766 |
|
|
2019
Q3 | $7.09M | Buy |
77,531
+16,903
| +28% | +$1.54M | ﹤0.01% | 2061 |
|
|
2019
Q2 | $5.49M | Buy |
60,628
+56,359
| +1,320% | +$4.95M | ﹤0.01% | 2244 |
|
|
2019
Q1 | $313K | Sell |
4,269
-2,160
| -34% | -$156K | ﹤0.01% | 4353 |
|
|
2018
Q4 | $434K | Sell |
6,429
-1,153
| -15% | -$81.4K | ﹤0.01% | 4375 |
|
|
2018
Q3 | $556K | Sell |
7,582
-20,087
| -73% | -$1.61M | ﹤0.01% | 4329 |
|
|
2018
Q2 | $2.23M | Buy |
27,669
+14,029
| +103% | +$1.05M | ﹤0.01% | 3064 |
|
|
2018
Q1 | $857K | Sell |
13,640
-2,793
| -17% | -$186K | ﹤0.01% | 3837 |
|
|
2017
Q4 | $1.04M | Buy |
16,433
+7,087
| +76% | +$505K | ﹤0.01% | 3753 |
|
|
2017
Q3 | $730K | Buy |
9,346
+5,079
| +119% | +$387K | ﹤0.01% | 3945 |
|
|
2017
Q2 | $334K | Sell |
4,267
-7,485
| -64% | -$522K | ﹤0.01% | 4413 |
|
|
2017
Q1 | $678K | Buy |
11,752
+737
| +7% | +$39.8K | ﹤0.01% | 3825 |
|
|
2016
Q4 | $547K | Buy |
11,015
+8,935
| +430% | +$464K | ﹤0.01% | 4040 |
|
|
2016
Q3 | $116K | Sell |
2,080
-1,088
| -34% | -$57.7K | ﹤0.01% | 4911 |
|
|
2016
Q2 | $148K | Sell |
3,168
-8,283
| -72% | -$361K | ﹤0.01% | 4753 |
|
|
2016
Q1 | $443K | Sell |
11,451
-1,942
| -15% | -$75.5K | ﹤0.01% | 3868 |
|
|
2015
Q4 | $660K | Buy |
13,393
+563
| +4% | +$24.8K | ﹤0.01% | 3732 |
|
|
2015
Q3 | $540K | Buy |
12,830
+1,244
| +11% | +$63.2K | ﹤0.01% | 3838 |
|
|
2015
Q2 | $629K | Sell |
11,586
-37,627
| -76% | -$2.02M | ﹤0.01% | 3923 |
|
|
2015
Q1 | $2.41M | Sell |
49,213
-230
| -0.5% | -$10.6K | ﹤0.01% | 2763 |
|
|
2014
Q4 | $2.36M | Buy |
+49,443
| New | +$2.14M | ﹤0.01% | 2745 |
|
Other funds holding MDSO
UBS Group's MDSO Position: Q4 2019 in Review
UBS Group sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 77,531 shares — an estimated $7.09M sold.
UBS Group first reported a position in MDSO in Q4 2014 and held it in 20 quarters. The position peaked at $7.09M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.
- UBS Group reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
- UBS Group sold 77,531 Medidata Solutions, Inc. shares in Q4 2019, an estimated $7.09M.
- UBS Group first reported a position in Medidata Solutions, Inc. in Q4 2014 and held it in 20 quarters.
- UBS Group's Medidata Solutions, Inc. position peaked at $7.09M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.